The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
about
Novel Strategies to Improve the Endocrine Therapy of Breast Cancer.Combined bortezomib-based chemotherapy and p53 gene therapy using hollow mesoporous silica nanospheres for p53 mutant non-small cell lung cancer treatment.Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor.Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells.A high throughput method to study the physiology of E2:ERα signaling in breast cancer cells.Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets.Network integration of multi-tumour omics data suggests novel targeting strategies
P2860
Q33727284-4B4C690A-A837-451D-B7DE-115B89F3A37EQ36185176-FF49C782-21C3-4805-A23E-71EF57AEDA88Q37715501-F3BC6BFD-40DF-4913-851B-9CF34800F9AFQ42563273-09BDD18E-BA2F-4A22-9BED-22EA2AC23FD8Q48089613-811753F6-9AF0-4CA7-BB38-352E876A0FDBQ53684285-8BEB3BEC-3843-4B94-B927-EE8C3D00F8A6Q58097633-4025D0DC-9694-49B2-BDC6-B27215318CA5
P2860
The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The proteasome inhibitor Borte ...... ceptor-positive breast cancer.
@en
type
label
The proteasome inhibitor Borte ...... ceptor-positive breast cancer.
@en
prefLabel
The proteasome inhibitor Borte ...... ceptor-positive breast cancer.
@en
P2093
P2860
P356
P1476
The proteasome inhibitor Borte ...... eceptor-positive breast cancer
@en
P2093
Arno Schad
Gitta Thiede
Marcus Schmidt
Sonja Thaler
P2860
P304
P356
10.1002/IJC.29404
P577
2015-01-08T00:00:00Z